Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 06/30
06-2019 | 06-2018 | 06-2017 | 06-2016 | 06-2015 | |
Sales | 7,320 | 3,660 | 3,222 | 2,562 | 262 |
Cost of Goods | 2,202 | 2,051 | 1,417 | 957 | 88 |
Gross Profit | 5,118 | 1,610 | 1,804 | 1,605 | 174 |
Operating Expenses | 22,167 | 21,360 | 22,347 | 24,267 | 7,894 |
Operating Income | -16,847 | -19,700 | -20,125 | -21,704 | -7,632 |
Interest Expense | 536 | 749 | 2,534 | 5,492 | 115 |
Other Income | -9,750 | 10,262 | 151 | -984 | 0 |
Pre-tax Income | -27,132 | -10,188 | -22,508 | -28,180 | -7,747 |
Income Tax | N/A | N/A | N/A | N/A | -24 |
Net Income Continuous | -27,132 | -10,188 | -22,508 | -28,180 | -7,723 |
Net Income | $-27,132 | $-10,188 | $-22,508 | $-28,180 | $-7,723 |
EPS Basic Total Ops | -696.00 | -3,062.00 | -9,660.00 | -1,294,800.00 | -805,599.90 |
EPS Basic Continuous Ops | -696.23 | -3,061.23 | -9,659.72 | -1,294,788.00 | -805,227.90 |
EPS Diluted Total Ops | -696.00 | -3,062.00 | -9,660.00 | -1,294,800.00 | -805,599.90 |
EPS Diluted Continuous Ops | -696.23 | -3,061.23 | -9,659.72 | -1,294,788.00 | -805,227.90 |
EPS Diluted Before Non-Recurring Items | -696.00 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-14,120 | $-17,109 | $-15,425 | $-15,582 | $-7,392 |